Gratus Capital LLC Edwards Lifesciences Corp Transaction History

Gratus Capital LLC

$2.39 Billion
Q2 2024

A detailed history of Gratus Capital LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Gratus Capital LLC holds 11,303 shares of EW stock, worth $736,503. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,303

Previous 9,896 14.22%

Holding current value

$736,503

Previous $945,000 10.48%

% of portfolio

0.04%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$84.3 - $94.31 $118,610 - $132,694	1,407 Added 14.22%	11,303 $1.04 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $250,988 - $330,637	-3,460 Reduced 25.91%	9,896 $945,000
Q4 2023 Feb 07, 2024	SELL	$61.71 - $77.76 $51,281 - $64,618	-831 Reduced 5.86%	13,356 $1.02 Million
Q3 2023 Oct 26, 2023	BUY	$69.28 - $93.38 $13,440 - $18,115	194 Added 1.39%	14,187 $982,000
Q2 2023 Aug 02, 2023	SELL	$81.41 - $94.33 $34,599 - $40,090	-425 Reduced 2.95%	13,993 $1.32 Million
Q1 2023 Apr 19, 2023	SELL	$74.26 - $84.51 $138,272 - $157,357	-1,862 Reduced 11.44%	14,418 $1.19 Million
Q4 2022 Jan 27, 2023	SELL	$68.3 - $87.44 $7.66 Million - $9.8 Million	-112,122 Reduced 87.32%	16,280 $0
Q3 2022 Nov 03, 2022	BUY	$82.37 - $107.29 $9.13 Million - $11.9 Million	110,827 Added 630.59%	128,402 $10.6 Million
Q1 2022 Apr 29, 2022	SELL	$101.96 - $128.34 $123,983 - $156,061	-1,216 Reduced 6.47%	17,575 $2.07 Million
Q4 2021 Jan 31, 2022	SELL	$106.37 - $130.68 $638 - $784	-6 Reduced 0.03%	18,791 $2.43 Million
Q2 2021 Aug 10, 2021	SELL	$83.84 - $104.76 $2.01 Million - $2.51 Million	-24,000 Reduced 56.08%	18,797 $1.95 Million
Q1 2021 May 04, 2021	SELL	$78.68 - $90.67 $377,664 - $435,216	-4,800 Reduced 10.08%	42,797 $3.58 Million
Q4 2020 Feb 03, 2021	SELL	$71.69 - $91.23 $207,399 - $263,928	-2,893 Reduced 5.73%	47,597 $4.34 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $1.88 Million - $2.51 Million	32,618 Added 182.51%	50,490 $3.49 Million
Q4 2019 Feb 07, 2020	SELL	$71.7 - $82.09 $78,870 - $90,299	-1,100 Reduced 5.8%	17,872 $4.17 Million
Q2 2019 Aug 07, 2019	SELL	$55.74 - $64.41 $20,902 - $24,153	-375 Reduced 1.94%	18,972 $3.51 Million
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $69,967 - $93,577	-1,461 Reduced 7.02%	19,347 $3.7 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $34,064 - $41,793	-734 Reduced 3.41%	20,808 $3.19 Million
Q3 2018 Nov 09, 2018	SELL	$45.7 - $58.03 $15,172 - $19,265	-332 Reduced 1.52%	21,542 $3.75 Million
Q2 2017 Aug 08, 2017	BUY	N/A	21,874	21,874 $2.59 Million

Others Institutions Holding EW

# of Institutions

1,418

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.

Account

Gratus Capital LLC Edwards Lifesciences Corp Transaction History